Aripiprazole Sandoz

Country: Evrópusambandið

Tungumál: enska

Heimild: EMA (European Medicines Agency)

Kauptu það núna

Vara einkenni Vara einkenni (SPC)
27-02-2024
Opinber matsskýrsla Opinber matsskýrsla (PAR)
25-09-2015

Virkt innihaldsefni:

aripiprazole

Fáanlegur frá:

Sandoz GmbH

ATC númer:

N05AX12

INN (Alþjóðlegt nafn):

aripiprazole

Meðferðarhópur:

Psycholeptics

Lækningarsvæði:

Schizophrenia; Bipolar Disorder

Ábendingar:

Aripiprazole Sandoz is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older. Aripiprazole Sandoz is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment. Aripiprazole Sandoz is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 years and older.,

Vörulýsing:

Revision: 9

Leyfisstaða:

Authorised

Leyfisdagur:

2015-08-20

Upplýsingar fylgiseðill

                                54
B. PACKAGE LEAFLET
55 PACKAGE LEAFLET: INFORMATION FOR THE USER
ARIPIPRAZOLE SANDOZ 5 MG TABLETS
ARIPIPRAZOLE SANDOZ 10 MG TABLETS
ARIPIPRAZOLE SANDOZ 15 MG TABLETS
ARIPIPRAZOLE SANDOZ 20 MG TABLETS
ARIPIPRAZOLE SANDOZ 30 MG TABLETS
aripiprazole
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even
if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not
listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Aripiprazole Sandoz tablets are and what they are used for
2.
What you need to know before you take Aripiprazole Sandoz tablets
3.
How to take Aripiprazole Sandoz tablets
4.
Possible side effects
5.
How to store Aripiprazole Sandoz tablets
6.
Contents of the pack and other information
1.
WHAT ARIPIPRAZOLE SANDOZ IS AND WHAT IT IS USED FOR
Aripiprazole Sandoz contains the active substance aripiprazole and
belongs to a group of medicines called
antipsychotics. It is used to treat adults and adolescents aged 15
years and older who suffer from a disease
characterised by symptoms such as hearing, seeing or sensing things
which are not there, suspiciousness,
mistaken beliefs, incoherent speech and behaviour and emotional
flatness. People with this condition may
also feel depressed, guilty, anxious or tense.
Aripiprazole Sandoz is used to treat adults and adolescents aged 13
years and older who suffer from a
condition with symptoms such as feeling "high", having excessive
amounts of energy, needing much less
sleep than usual, talking very quickly with racing ideas and sometimes
severe irritability. In adults it also
prevents this condition from returning in patients who have responded
to the treatment w
                                
                                Lestu allt skjalið
                                
                            

Vara einkenni

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Aripiprazole Sandoz 5 mg tablets
Aripiprazole Sandoz 10 mg tablets
Aripiprazole Sandoz 15 mg tablets
Aripiprazole Sandoz 20 mg tablets
Aripiprazole Sandoz 30 mg tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Aripiprazole Sandoz 5 mg tablets
Each tablet contains 5 mg of aripiprazole.
Excipient with known effect
67.47 mg lactose (as monohydrate) per tablet.
Aripiprazole Sandoz 10 mg tablets
Each tablet contains 10 mg of aripiprazole.
Excipient with known effect
62.67 mg lactose (as monohydrate) per tablet.
Aripiprazole Sandoz 15 mg tablets
_ _
Each tablet contains 15 mg of aripiprazole.
Excipient with known effect
92.86 mg lactose (as monohydrate) per tablet.
Aripiprazole Sandoz 20 mg tablets
Each tablet contains 20 mg of aripiprazole.
Excipient with known effect
125.72 mg lactose (as monohydrate) per tablet.
Aripiprazole Sandoz 30 mg tablets
Each tablet contains 30 mg of aripiprazole.
Excipient with known effect
186.68 mg lactose (as monohydrate) per tablet.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet
Aripiprazole Sandoz 5 mg tablets
3
Blue coloured, mottled, round shaped tablet, with an approximate
diameter of 6.0 mm, debossed with “SZ”
on one side and “444” on the other side.
Aripiprazole Sandoz 10 mg tablets
Pink coloured, mottled, round shaped tablet, with an approximate
diameter of 6.0 mm, debossed with “SZ”
on one side and “446” on the other side.
Aripiprazole Sandoz 15 mg tablets
Yellow coloured, mottled, round shaped tablet, with an approximate
diameter of 7.0 mm, debossed with
“SZ” on one side and “447” on the other side.
Aripiprazole Sandoz 20 mg tablets
White coloured, round shaped tablet, with an approximate diameter of
7.8 mm, debossed with “SZ” on one
side and “448” on the other side.
_ _
_ _
Aripiprazole Sandoz 30 mg tablets
Pink coloured, mottled, round shaped tablet, with an approximate
diameter of 9.0 mm, debossed with “SZ”
on one side and 
                                
                                Lestu allt skjalið
                                
                            

Skjöl á öðrum tungumálum

Upplýsingar fylgiseðill Upplýsingar fylgiseðill búlgarska 27-02-2024
Vara einkenni Vara einkenni búlgarska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla búlgarska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill spænska 27-02-2024
Vara einkenni Vara einkenni spænska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla spænska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill tékkneska 27-02-2024
Vara einkenni Vara einkenni tékkneska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla tékkneska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill danska 27-02-2024
Vara einkenni Vara einkenni danska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla danska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill þýska 27-02-2024
Vara einkenni Vara einkenni þýska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla þýska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill eistneska 27-02-2024
Vara einkenni Vara einkenni eistneska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla eistneska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill gríska 27-02-2024
Vara einkenni Vara einkenni gríska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla gríska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill franska 27-02-2024
Vara einkenni Vara einkenni franska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla franska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill ítalska 27-02-2024
Vara einkenni Vara einkenni ítalska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla ítalska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill lettneska 27-02-2024
Vara einkenni Vara einkenni lettneska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla lettneska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill litháíska 27-02-2024
Vara einkenni Vara einkenni litháíska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla litháíska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill ungverska 27-02-2024
Vara einkenni Vara einkenni ungverska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla ungverska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill maltneska 27-02-2024
Vara einkenni Vara einkenni maltneska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla maltneska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill hollenska 27-02-2024
Vara einkenni Vara einkenni hollenska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla hollenska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill pólska 27-02-2024
Vara einkenni Vara einkenni pólska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla pólska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill portúgalska 27-02-2024
Vara einkenni Vara einkenni portúgalska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla portúgalska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill rúmenska 27-02-2024
Vara einkenni Vara einkenni rúmenska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla rúmenska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill slóvakíska 27-02-2024
Vara einkenni Vara einkenni slóvakíska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla slóvakíska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill slóvenska 27-02-2024
Vara einkenni Vara einkenni slóvenska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla slóvenska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill finnska 27-02-2024
Vara einkenni Vara einkenni finnska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla finnska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill sænska 27-02-2024
Vara einkenni Vara einkenni sænska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla sænska 25-09-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill norska 27-02-2024
Vara einkenni Vara einkenni norska 27-02-2024
Upplýsingar fylgiseðill Upplýsingar fylgiseðill íslenska 27-02-2024
Vara einkenni Vara einkenni íslenska 27-02-2024
Upplýsingar fylgiseðill Upplýsingar fylgiseðill króatíska 27-02-2024
Vara einkenni Vara einkenni króatíska 27-02-2024
Opinber matsskýrsla Opinber matsskýrsla króatíska 25-09-2015

Leitaðu viðvaranir sem tengjast þessari vöru